Page last updated: 2024-09-05

bifeprunox and mesulergine

bifeprunox has been researched along with mesulergine in 1 studies

Compound Research Comparison

Studies
(bifeprunox)
Trials
(bifeprunox)
Recent Studies (post-2010)
(bifeprunox)
Studies
(mesulergine)
Trials
(mesulergine)
Recent Studies (post-2010) (mesulergine)
301122651028

Protein Interaction Comparison

ProteinTaxonomybifeprunox (IC50)mesulergine (IC50)
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.0019
5-hydroxytryptamine receptor 7Homo sapiens (human)0.205
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)0.0021
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.0052
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)0.0021

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Christoffersen, CT; Jensen, AA; Kehler, J; Krogsgaard-Larsen, N; Schrøder, TJ1

Other Studies

1 other study(ies) available for bifeprunox and mesulergine

ArticleYear
Novel aza-analogous ergoline derived scaffolds as potent serotonin 5-HT₆ and dopamine D₂ receptor ligands.
    Journal of medicinal chemistry, 2014, Jul-10, Volume: 57, Issue:13

    Topics: Ergolines; Humans; Ligands; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists

2014